Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits

Paula R Augusti, Andréia Quatrin, Sabrina Somacal, Greicy Mm Conterato, Rocheli Sobieski, Amanda R Ruviaro, Luana H Maurer, Marta Mf Duarte, Miguel Roehrs, Tatiana Emanuelli, Paula R Augusti, Andréia Quatrin, Sabrina Somacal, Greicy Mm Conterato, Rocheli Sobieski, Amanda R Ruviaro, Luana H Maurer, Marta Mf Duarte, Miguel Roehrs, Tatiana Emanuelli

Abstract

This study explored the effects of the antioxidant astaxanthin on paraoxonase and thioredoxin reductase activities as well as on other oxidative stress parameters and on the lipid profile in hypercholesterolemic rabbits. Rabbits were fed a standard or a hypercholesterolemic diet alone or supplemented with 50, 100 and 500 mg/100 g of astaxanthin for 60 days. Antioxidant enzymes activities, lipid profile and oxidative stress markers were evaluated in the serum. The hypercholesterolemic diet increased lipids, including unsaturated fatty acids level, whereas it decreased saturated fatty acids level. These changes were accompanied by increased levels of oxidized low-density lipoprotein and oxidized low-density lipoprotein antibodies, as well as lipid and protein oxidation. Astaxanthin (100 and 500 mg/100 g) prevented hypercholesterolemia-induced protein oxidation, whereas 500 mg/100 g of astaxanthin decreased protein oxidation per se. The activities of superoxide dismutase and thioredoxin reductase were enhanced, whereas paraoxonase activity was inhibited in hypercholesterolemic rabbits. All astaxanthin doses prevented changes in thioredoxin reductase and paraoxonase activities. This effect was not related to a direct effect of astaxanthin on these enzymes, because in vitro astaxanthin enhanced thioredoxin reductase and had no effect on paraoxonase activity. Astaxanthin could be helpful in cardiovascular diseases by restoring thioredoxin reductase and paraoxonase activities.

Keywords: atherosclerosis; fatty acids; oxidative stress.

Figures

Fig. 1
Fig. 1
Total cholesterol (A), triglycerides (B), HDL (C) and non-HDL cholesterol (D) levels of rabbits fed with a cholesterol and/or ASX enriched diet (means ± SEM, n = 6). *Different from control groups (p<0.05).
Fig. 2
Fig. 2
TBARS levels (A), protein carbonyl content (B), LDLox (C) and LDLoxAB (D) levels of rabbits fed with a cholesterol and/or ASX enriched diet (means ± SEM, n = 6). *Different from control groups (p<0.05). #Different from ASX 0-Chol group (p<0.05). &Different from ASX 0-control group (p<0.05). MDA = malondialdehyde.
Fig. 3
Fig. 3
PON1 (A), SOD (B) and TrxR-1 (C) activities of rabbits fed with a cholesterol and/or ASX enriched diet (means ± SEM, n = 6). *Different from control groups (p<0.05). #Different from ASX 0-Chol group (p<0.05).
Fig. 4
Fig. 4
In vitro effect of ASX on serum TrxR-1 (A) and PON1 (B) activities from rabbits. Serum was preincubated for 1 h in the presence of 0, 3, 10, 30 or 100 µg/ml of ASX. Then, the activities of TrxR-1 and PON1 were determined as described in Materials and Methods section. Data are means ± SEM (n = 4). *Different from control (0 µg ASX/ml) at p<0.05.

References

    1. Kruth HS. Lipoprotein cholesterol and atherosclerosis. Curr Mol Med. 2001;1:633–653.
    1. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J. 1993;125:958–973.
    1. Duarte MM, Rocha JB, Moresco RN, et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem. 2009;42:666–671.
    1. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995;91:2488–2496.
    1. Kondo A, Murunaka Y, Ohta I, et al. Relationships between triglyceride concentrations and LDL size evaluated by malonadehyde-modified LDL. Clin Chem. 2001;47:893–900.
    1. Nordberg J, Arnér ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med. 2001;31:1287–1312.
    1. Furman C, Rundlöf AK, Larigauderie G, et al. Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins. Free Radic Biol Med. 2004;37:71–85.
    1. Wu Y, Yang L, Zhong L. Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity. Atherosclerosis. 2010;212:351–355.
    1. Jekell A, Hossain A, Alehagen U, Dahlström U, Rosé A. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail. 2004;6:883–890.
    1. Aviram M. Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. Free Radic Biol Med. 2004;37:1301–1303.
    1. Mackness B, Durrington P, McElduff P, et al. Low paraoxonase activity predicts coronary events in the Caerphilly prospective study. Circulation. 2003;107:2775–2779.
    1. Madrid AE, Vásques ZD, Levton AF, Mandiola C, Escobar FJA. Short-term Lycopersicum esculentum consumption may increase plasma high density lipoproteins and decrease oxidative stress. Rev Med Chil. 2006;134:855–862.
    1. Kurashige M, Okimasu E, Inoue M, Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR. 1990;22:27–38.
    1. Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;22:580–680.
    1. Jacobsson LS, Yuan XM, Ziedén B, Olsson AG. Effects of α-tocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits. Atherosclerosis. 2004;173:231–237.
    1. Augusti PR, Conterato GM, Somacal S, et al. Astaxanthin reduces oxidative stress, but not aortic damage in atherosclerotic rabbits. J Cardiovasc Pharmacol Ther. 2009;14:314–322.
    1. Iwamoto T, Hosoda K, Hirano R, et al. Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb. 2000;7:216–222.
    1. Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan XM. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol. 2004;37:969–978.
    1. Choi HD, Kang HE, Yang SH, Lee MG, Shin WG. Pharmacokinetics and first-pass metabolism of astaxanthin in rats. Br J Nutr. 2011;105:220–227.
    1. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation. 1999;99:1355–1362.
    1. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358.
    1. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–478.
    1. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:100–107.
    1. Wu R, Lefvert AK. Autoantibodies against oxidized low density lipoprotein (OxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol. 1995;102:174–180.
    1. Bolayirli IM, Aslan M, Balci H, Altug T, Hacibekiroglu M, Seven A. Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. Life Sci. 2007;81:121–127.
    1. Holmgren A, Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995;252:199–208.
    1. Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide-dismutase. J Biol Chem. 1972;247:3170–3175.
    1. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114–120.
    1. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275.
    1. Park JS, Kim HW, Mathison BD, et al. Astaxanthin uptake in domestic dogs and cats. Nutr Metab (Lond) 2010;7:52.
    1. Coral-Hinostroza GN, Ytrestøyl T, Ruyter B, Bjerkeng B. Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3'R/S isomers of astaxanthin fatty acyl diesters. Comp Biochem Physiol C Toxicol Pharmacol. 2004;139:99–110.
    1. Ntambi JM. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res. 1999;40:1549–1558.
    1. Rose HG. Origin of cholesterol esters in the blood of cholesterol-fed rabbits: relative contributions of serum lecithin-cholesterol acyltransferase and hepatic ester synthesis. Biochim Biophys Acta. 1972;260:312–326.
    1. Farmer JA, Gotto AM., Jr Dyslipidemia and the vulnerable plaque. Prog Cardiovasc Dis. 2002;44:415–428.
    1. Balkan J, Kanbağli O, Mehmetçik G, Mutlu-Türkoğlu U, Aykaç-Toker G, Uysal M. Increased lipid peroxidation in serum and low-density lipoproteins associated with aging in humans. Int J Vitam Nutr Res. 2002;72:315–320.
    1. Bell JG, McEvoy J, Tocher DR, Sargent JR. Depletion of α-tocopherol and astaxanthin in Atlantic salmon (Salmo salar) affects autoxidative defense and fatty acid metabolism. J Nutr. 2000;130:1800–1808.
    1. Wingerath T, Stahl W, Sies H. Beta-cryptoxanthin selectively increases in human chylomicrons upon ingestion of tangerine concentrate rich in beta-cryptoxanthin esters. Arch Biochem Biophys. 1995;324:385–390.
    1. Shaw PX, Hörkkö S, Tsimikas S, et al. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol. 2001;21:1333–1339.
    1. Augusti PR, Conterato GM, Somacal S, et al. Effect of astaxanthin on kidney function impairment and oxidative stress induced by mercuric chloride in rats. Food Chem Toxicol. 2008;46:212–219.
    1. Aas GH, Bjerkeng B, Storebakken T, Ruyter B. Blood appearance, metabolic transformation and plasma transport proteins of 14C-astaxanthin in Atlantic salmon (Salmo salar L.) Fish Physiol Biochem. 1999;21:325–334.
    1. Strålin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15:2032–2036.
    1. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546–2551.
    1. Söderberg A, Sahaf B, Rosén A. Thioredoxin reductase, a redoxactive selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res. 2000;60:2281–2289.
    1. Björnstedt M, Hamberg M, Kumar S, Xue J, Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem. 1995;270:11761–11764.
    1. Hokamaki J, Kawano H, Soejima H, et al. Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol. 2005;99:225–231.
    1. Furman C, Rundlöf AK, Larigauderie G, et al. Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins. Free Radic Biol Med. 2004;37:71–85.
    1. Wu X, Kang J, Xie C, et al. Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression. J Nutr. 2010;140:1628–1632.
    1. Sezer EB, Sozmen EY, Nart D, Onat T. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation. Vasc Health Risk Manag. 2011;7:333–343.
    1. Mackness M, Boullier A, Hennuyer N, et al. Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits. Biochem Biophys Res Commun. 2000;269:232–236.
    1. Rajasingh H, Øyehaug L, Våge DI, Omholt SW. Carotenoid dynamics in Atlantic salmon. BMC Biol. 2006;4:10.
    1. Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 1995;115:243–253.
    1. Kwon EY, Do GM, Cho YY, Park YB, Jeon SM, Choi MS. Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: comparison with clofibrate. Food Chem Toxicol. 2010;48:2298–2303.
    1. Leckey LC, Garige M, Varatharajalu R, et al. Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene Eexpression and PON1 activity in LDLR−/− mice. Alcohol Clin Exp Res. 2010;34:1535–1542.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren